164 related articles for article (PubMed ID: 22278362)
1. Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
Chacko AD; McDade SS; Chanduloy S; Church SW; Kennedy R; Price J; Hall PA; Russell SE
Cell Oncol (Dordr); 2012 Apr; 35(2):85-93. PubMed ID: 22278362
[TBL] [Abstract][Full Text] [Related]
2. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
[TBL] [Abstract][Full Text] [Related]
3. Mammalian SEPT9 isoforms direct microtubule-dependent arrangements of septin core heteromers.
Sellin ME; Stenmark S; Gullberg M
Mol Biol Cell; 2012 Nov; 23(21):4242-55. PubMed ID: 22956766
[TBL] [Abstract][Full Text] [Related]
4. Regulation of microtubule plus end dynamics by septin 9.
Nakos K; Rosenberg M; Spiliotis ET
Cytoskeleton (Hoboken); 2019 Jan; 76(1):83-91. PubMed ID: 30144301
[TBL] [Abstract][Full Text] [Related]
5. Septin-microtubule association via a motif unique to isoform 1 of septin 9 tunes stress fibers.
Kuzmić M; Castro Linares G; Leischner Fialová J; Iv F; Salaün D; Llewellyn A; Gomes M; Belhabib M; Liu Y; Asano K; Rodrigues M; Isnardon D; Tachibana T; Koenderink GH; Badache A; Mavrakis M; Verdier-Pinard P
J Cell Sci; 2022 Jan; 135(1):. PubMed ID: 34854883
[TBL] [Abstract][Full Text] [Related]
6. Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms.
Iv F; Martins CS; Castro-Linares G; Taveneau C; Barbier P; Verdier-Pinard P; Camoin L; Audebert S; Tsai FC; Ramond L; Llewellyn A; Belhabib M; Nakazawa K; Di Cicco A; Vincentelli R; Wenger J; Cabantous S; Koenderink GH; Bertin A; Mavrakis M
J Cell Sci; 2021 Aug; 134(15):. PubMed ID: 34350965
[TBL] [Abstract][Full Text] [Related]
7. Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes.
Froidevaux-Klipfel L; Targa B; Cantaloube I; Ahmed-Zaïd H; Poüs C; Baillet A
Oncotarget; 2015 Nov; 6(34):36063-80. PubMed ID: 26460824
[TBL] [Abstract][Full Text] [Related]
8. Properties of SEPT9 isoforms and the requirement for GTP binding.
Robertson C; Church SW; Nagar HA; Price J; Hall PA; Russell SE
J Pathol; 2004 May; 203(1):519-27. PubMed ID: 15095474
[TBL] [Abstract][Full Text] [Related]
9. SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.
Amir S; Mabjeesh NJ
Cancer Biol Ther; 2007 Dec; 6(12):1926-31. PubMed ID: 18075300
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.
Devlin L; Okletey J; Perkins G; Bowen JR; Nakos K; Montagna C; Spiliotis ET
Proteomics; 2021 Oct; 21(19):e2100155. PubMed ID: 34409731
[TBL] [Abstract][Full Text] [Related]
11. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
[TBL] [Abstract][Full Text] [Related]
12. Translational control of SEPT9 isoforms is perturbed in disease.
McDade SS; Hall PA; Russell SE
Hum Mol Genet; 2007 Apr; 16(7):742-52. PubMed ID: 17468182
[TBL] [Abstract][Full Text] [Related]
13. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
[TBL] [Abstract][Full Text] [Related]
14. An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry.
Hecht M; Rösler R; Wiese S; Johnsson N; Gronemeyer T
G3 (Bethesda); 2019 Jun; 9(6):1869-1880. PubMed ID: 30975701
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission.
Estey MP; Di Ciano-Oliveira C; Froese CD; Bejide MT; Trimble WS
J Cell Biol; 2010 Nov; 191(4):741-9. PubMed ID: 21059847
[TBL] [Abstract][Full Text] [Related]
16. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
[TBL] [Abstract][Full Text] [Related]
17. SEPT9_v4 expression induces morphological change, increased motility and disturbed polarity.
Chacko AD; Hyland PL; McDade SS; Hamilton PW; Russell SH; Hall PA
J Pathol; 2005 Aug; 206(4):458-65. PubMed ID: 15902694
[TBL] [Abstract][Full Text] [Related]
18. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
19. SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission.
Kim MS; Froese CD; Estey MP; Trimble WS
J Cell Biol; 2011 Nov; 195(5):815-26. PubMed ID: 22123865
[TBL] [Abstract][Full Text] [Related]
20. SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.
Peterson EA; Stanbery L; Li C; Kocak H; Makarova O; Petty EM
Genes Chromosomes Cancer; 2011 Nov; 50(11):940-9. PubMed ID: 21910160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
